Showing 1 - 10 of 32
US approves maternal vaccine to prevent RSV in infants
AFP, Published on 22/08/2023
» WASHINGTON - The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
UK unveils $3bn backing for Ukraine reconstruction
AFP, Published on 21/06/2023
» LONDON - The UK will back Ukraine's economy to the tune of $3 billion over the next three years while it fights back against Russian forces, Prime Minister Rishi Sunak announced on Tuesday.
US issues world's first approval of RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved the world's first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades long hunt to protect vulnerable people from the common illness.
US approves world's first RSV vaccine
AFP, Published on 04/05/2023
» WASHINGTON - The United States on Wednesday approved GSK's Arexy vaccine against Respiratory Syncytial Virus (RSV), which can cause severe pneumonia and bronchiolitis in infants and the elderly.
Sanofi, joining other drug makers, slashes US insulin price
AFP, Published on 17/03/2023
» NEW YORK - French pharmaceutical giant Sanofi announced on Thursday it would cut the US price of its most prescribed insulin by 78 percent, falling in line with two other major drug makers.
US drugmaker Eli Lilly says slashing insulin prices
AFP, Published on 02/03/2023
» NEW YORK - US pharmaceutical giant Eli Lilly announced Wednesday it would cut the cost of its insulin by 70 percent, with President Joe Biden calling on others to follow suit to tackle soaring drug prices.
EU watchdog backs Sanofi Covid booster jab
AFP, Published on 11/11/2022
» THE HAGUE - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.
A year of Covid jabs, but treatments lag behind
AFP, Published on 03/12/2021
» PARIS: After a year of vaccines aimed at preventing Covid, treatments for people infected with the virus are few, with most restricted to hospital use and extremely pricey.
GSK's Walmsley battles hostile investors and Covid slump
AFP, Published on 28/07/2021
» LONDON - The head of the British pharmaceutical giant GSK, Emma Walmsley, will present the company's quarterly results on Wednesday as criticism mounts over ineffective management and delays in Covid-19 vaccine production.
Britain eases virus lockdown but Asia outbreaks fuel concern
AFP, Published on 17/05/2021
» LONDON - Britons streamed into pubs, museums and other indoor venues on Monday as the country eased pandemic restrictions, but there was even more misery in India where a powerful cyclone disrupted efforts to fight a devastating Covid-19 wave.